Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Conference
Enlyte Envision 2026
.gradient-text { background-image:linear-gradient(90deg, #5023FA 0%, #BE18B3 100%); color: transparent; background-clip: text; }
Workers' Comp
White Paper
Going Beyond Algorithms With Clinician & AI Collaboration
Workers' Comp
Article
Ask The Pharmacist: Managing Benzodiazepine Tapering in Injury Claims
How can safer benzodiazepine tapering improve recovery? Benzodiazepines (BZDs) are frequently prescribed for anxiety, insomnia and mu
Workers' Comp
Article
Mental Health Is the Hidden Factor Delaying Recovery
In workers’ comp, not every injury shows up on an X-ray.
WCI-TV
In the News
WCI-TV Interview with Nicole Usher
WCI-TV
In the News